Delta University for Science and Technology recently announced an upcoming clinical trial to investigate the link between cervical deep flexor endurance and proprioception function in individuals diagnosed with cervical radiculopathy. This study, highlighted on ClinicalTrials.gov, will employ a specialized cervical range of motion device to assess patients. The trial is not yet recruiting participants.
In this article:
- What is the clinical trial about?
- What is the cervical range of motion device?
- Why this study matters?
- Frequently asked questions
- Conclusion
- Disclaimer
- Announcement and source link
What is the clinical trial about?
The study aims to explore the relationship between the endurance of cervical deep flexors—muscles critical for neck stability—and their connection to proprioception, the body’s sense of position and movement. Cervical radiculopathy, a condition caused by nerve root compression in the cervical spine, often results in pain and impaired mobility, making understanding these factors vital for effective treatment strategies.
By assessing the endurance capacity of the cervical deep flexors, researchers hope to deepen their understanding of how muscle function correlates with proprioceptive abilities in affected individuals. Findings may pave the way for targeted rehabilitation approaches for patients experiencing cervical radiculopathy.
What is the cervical range of motion device?
The cervical range of motion device, utilized in the study’s intervention, focuses on precisely measuring neck mobility and stability. Devices like this are pivotal in gathering objective data regarding muscular endurance and alignment, aiding medical teams in providing evidence-based interventions.
Although specific device details have not been disclosed in this listing, such devices often leverage advanced sensors and biofeedback to monitor motion and muscle use accurately. Regulatory bodies play a critical role in overseeing safe use during clinical research like this.
Why this study matters?
The prevalence of cervical radiculopathy makes innovative solutions essential for optimizing clinical interventions. Current approaches may not address key correlations between muscle endurance and proprioceptive function, limiting therapeutic outcomes.
For clinical and regulatory teams who handle medical devices, this announcement serves as both a scientific opportunity and a reminder of device responsibilities. Using specialized devices in trials requires strict adherence to study protocols, patient safety considerations, and performance validation metrics. Institutions like Delta University are setting an example by advancing research in this area, potentially guiding future device technologies and treatment approaches.
Frequently asked questions
- What is cervical radiculopathy?
Cervical radiculopathy is a condition resulting from nerve root compression in the neck, causing pain, weakness, and sensory loss. - What does proprioception mean?
Proprioception refers to the body’s ability to sense its position, movement, and coordination. - Is this study currently recruiting?
No, the trial is marked as “not yet recruiting.” Future updates will provide enrollment timelines.
Conclusion
This announcement holds implications for clinical, quality, and regulatory teams in the healthcare device industry. Understanding cervical flexor endurance and proprioception could significantly influence therapeutic approaches and device development for cervical radiculopathy. Staying updated on recruiting timelines and study outcomes may help stakeholders prepare for emerging insights in this field.
Disclaimer
All information is provided for professional purposes and does not constitute legal advice. Consult relevant regulatory and clinical resources before making decisions based on clinical trial data.
Announcement and source link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07321119?term=medical+device